How big is the Drug Delivery Devices Market?

The Drug Delivery Devices Market size is expected to reach USD 191.79 billion in 2024 and grow at a CAGR of 9.01% to reach USD 295.23 billion by 2029. Read More

What is the current Drug Delivery Devices Market size?

In 2024, the Drug Delivery Devices Market size is expected to reach USD 191.79 billion. Read More

Who are the key players in Drug Delivery Devices Market?

Biocorp, Becton, Dickinson and Company, West Pharmaceutical Services Inc., Elcam Medical and Holozymes Inc. (Antares Pharma Inc.) are the major companies operating in the Drug Delivery Devices Market. Read More

Which is the fastest growing region in Drug Delivery Devices Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Drug Delivery Devices Market?

In 2024, the North America accounts for the largest market share in Drug Delivery Devices Market. Read More

What years does this Drug Delivery Devices Market cover, and what was the market size in 2023?

In 2023, the Drug Delivery Devices Market size was estimated at USD 175.94 billion. The report covers the Drug Delivery Devices Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Drug Delivery Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Drug Delivery Devices Market Share

Statistics for the 2023 & 2024 Drug Delivery Devices market share, created by Mordor Intelligence™ Industry Reports. Drug Delivery Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Drug Delivery Devices Industry

The drug delivery device market is moderately competitive and consists of several major players. Some of the companies currently dominating the market are Pfizer Inc., Novartis AG, F Hoffmann-La Roche Ltd, Johnson & Johnson, Bayer AG, Becton, Dickinson & Company, Altaris, Holozymes Inc. (Antares Pharma Inc.), GlaxoSmithKline PLC, Teva Pharmaceutical Industries Ltd, Biocorp, Merck KGaA, West Pharmaceutical Services Inc., Molex (Philips Medisize), and Elcam Medical, among others. The major players have focused on strategic alliances, such as acquisitions, collaborations, investment in R&D activities, and launching new products, to secure their position in a competitive global market